Consensus definitions for pediatric MS and other demyelinating disorders in childhood
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received August 19, 2015
- Accepted in final form March 1, 2016
- First Published August 29, 2016.
Author Disclosures
- Marc Tardieu, MD, PhD,
- Brenda Banwell, MD,
- Jerry S. Wolinsky, MD,
- Daniela Pohl, MD, PhD and
- Lauren B. Krupp, MD
- Marc Tardieu, MD, PhD,
1. Scientific advisory board for Biogen, Genzyme and Novartis for new treatment in pediatric MS.
NONE
NONE
Multiple sclerosis Journal
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Brenda Banwell, MD,
Scientific Advisory Board, Biogen-IDEC, Sanofi, Eli Lilly, Novartis.
NONE
I have received speaker's honoraria or travel support to speak at sponsored meetings from Biogen-IDEC, Merck- Serono, Teva Neuroscience and Bayer. I have not received this for more than 2 years.
I serve on the Editorial Board for Neurology. I receive no financial remuneration. I also serve on the Editorial Board for a new journal, Multiple Sclerosis and Related Disorders. I receive compensation for this work .
NONE
NONE
NONE
I have served as a consultant to Biogen-IDEC, Eli Lilly, Sanofi.
I have spoken at an event supported by the Consortium of MS Centers
NONE
NONE
NONE
NONE
NONE
Multiple Sclerosis Society of Canada Multiple Sclerosis Scientific Research Foundation National Multiple Sclerosis Society
NONE
NONE
NONE
NONE
NONE
NONE
- Jerry S. Wolinsky, MD,
Compensation for service on steering committees or data monitoring boards for Forward Pharma, Novartis Pharmaceuticals, Roche/Genentech, and Sanofi/Genzyme.
NONE
(1) Honoraria were provided from ACTRIMS, AcademicCME, WebMD, and the University of Kansas for CME activities. (2) Travel support was provided from ECTRIMS as invited faculty to the Barcelona meeting, and ACTRIMS as Keynote Speaker for the New Orleans meeting.
(1) Multiple Sclerosis Journal, Sage, Editorial Board, 1994 - present (2) Multiple Sclerosis and Related Diseases, Elsevier, Section Editor, 2011 - present
NONE
NONE
NONE
Reimbursement for services as consultant to AbbVie, Acetilon, Alkermes, Forward Pharma, EMD Serono, Genzyme, Novartis, Roche, Taketa, Teva, and XenoPort.
NONE
NONE
NONE
(1) Genzyme (2) Teva
(1) National Institutes of Health, 2 U01 NS045719-07 (PI of the subcontract to UTHSCH for image analysis), 2002 - 2015 (2) National Institutes of Health, NS078244-01A1 (Co- investigator), 2012 - 2017
NONE
NONE
NONE
(1) Royalties are received for monoclonal antibodies out-licensed through the University of Texas Health Science Center at Houston to Millipore (Chemicon International) Corporation since 1993.
NONE
NONE
NONE
NONE
- Daniela Pohl, MD, PhD and
(1) Biogen-Idec (2) Novartis (3) Sanofi (4) Merck-Serono
NONE
(1) EAN: Funding for travel (2) LACTRIMS: Funding for travel
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Lauren B. Krupp, MD
Dr. Krupp has served on the scientific advisory boards for Acorda , Genentech, Pfizer, Sanofi-Aventis, Novartis
NONE
Dr. Krupp served on the speakers? bureau for Bayer, Biogen Idec, TevaNeuroscience, EMD-Serono, National MS Society
NONE
NONE
NONE
NONE
Dr. Krupp is a consultant for Gerson Lehrman Group; Guidepoint Global; Axon Advisors
Dr. Krupp served on the speakers? bureau for Bayer, Biogen Idec, TevaNeuroscience, EMD-Serono and Multiple Sclerosis Association of America
NONE
NONE
Dr. Krupp has received research support from Biogen Idec, EMD-Serono, TevaNeurosciences, Novartis, Genentech, Celgene Corporation, Garnett McKeen Laboratory Incorporated
National Institutes of Health (grant 2 R01 HD38107) PI 2004-2008
NONE
Dr. Krupp has received research support from National Multiple Sclerosis Society (NMSS), Lourie Foundation, Slomo and Cindy Silvian Foundation, Multiple Sclerosis (MS) Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- From the National Reference Center for Inflammatory Diseases of the Brain (M.T.), Hôpitaux Universitaires Paris-Sud, University Paris-Sud, France; Perelman School of Medicine (B.B.), The Children's Hospital of Philadelphia, University of Pennsylvania; University of Texas Health Science Center at Houston (J.W.); Department of Neurology (D.P.), Children's Hospital of Eastern Ontario, University of Ottawa, Canada; and Lourie Center for Pediatric MS (L.B.K.), Stony Brook Children's, NY.
- Correspondence to Dr. Tardieu: marc.tardieu{at}bct.aphp.fr
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
MRI in the evaluation of pediatric multiple sclerosisBrenda Banwell, Douglas L. Arnold, Jan-Mendelt Tillema et al.Neurology, August 29, 2016 -
Article
International Pediatric MS Study Group Global Members Symposium reportEvangeline Wassmer, Tanuja Chitnis, Daniela Pohl et al.Neurology, August 29, 2016 -
Introduction
Pediatric demyelinating disordersGlobal updates, controversies, and future directionsTanuja Chitnis, Daniela Pohl et al.Neurology, August 29, 2016 -
Articles
Challenges in the classification of pediatric multiple sclerosis and future directionsAnita L. Belman, Tanuja Chitnis, Christel Renoux et al.Neurology, April 16, 2007